Does RUXOLITINIB Cause Extra dose administered? 72 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 72 reports of Extra dose administered have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.1% of all adverse event reports for RUXOLITINIB.
72
Reports of Extra dose administered with RUXOLITINIB
0.1%
of all RUXOLITINIB reports
6
Deaths
7
Hospitalizations
How Dangerous Is Extra dose administered From RUXOLITINIB?
Of the 72 reports, 6 (8.3%) resulted in death, 7 (9.7%) required hospitalization, and 1 (1.4%) were considered life-threatening.
Is Extra dose administered Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 72 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Extra dose administered?
TIRZEPATIDE (6,774)
DULAGLUTIDE (3,047)
LORATADINE (1,556)
DUPILUMAB (1,422)
FEXOFENADINE (1,413)
NAPROXEN (908)
POLYETHYLENE GLYCOL 3350 (589)
ACETAMINOPHEN (552)
DALFAMPRIDINE (519)
FLUTICASONE\SALMETEROL (499)
Which RUXOLITINIB Alternatives Have Lower Extra dose administered Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE